(NYSE: BLCO) Bausch & Lomb's forecast annual revenue growth rate of 7.48% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.54%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Bausch & Lomb's revenue in 2024 is $4,146,000,000.On average, 6 Wall Street analysts forecast BLCO's revenue for 2024 to be $1,632,778,007,274, with the lowest BLCO revenue forecast at $1,623,339,123,875, and the highest BLCO revenue forecast at $1,640,374,532,389. On average, 5 Wall Street analysts forecast BLCO's revenue for 2025 to be $1,722,499,697,406, with the lowest BLCO revenue forecast at $1,699,739,605,409, and the highest BLCO revenue forecast at $1,738,688,161,638.
In 2026, BLCO is forecast to generate $1,805,634,667,106 in revenue, with the lowest revenue forecast at $1,769,436,135,101 and the highest revenue forecast at $1,830,775,539,488.